GlassScriptPhysician profile
John J Mccrosson
NPI 1407881709
$175,578.32
in general payments reported to CMS, 2019-2025
17 companies · $20K in 2025
The $20K reported for 2025 was more than what 81% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40K · 2020: $22K · 2021: $26K · 2022: $36K · 2023: $9,824 · 2024: $22K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $39K · Travel and Lodging: $8,694 · Food and Beverage: $3,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $39,200.00 |
| Travel and Lodging | $8,693.57 |
| Food and Beverage | $3,199.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $113,332.24 | 2019-2025 | Mako, Aequalis, Triathlon |
| Exactech, INC. | $52,241.08 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $5,641.67 | 2019-2025 | Comprehensive Shoulder System |
| Depuy Synthes Sales INC. | $1,373.77 | 2019-2025 | Attune, Actis |
| Medacta USA, INC. | $1,177.76 | 2019-2021 | |
| Medical Device Business Services, INC. | $383.15 | 2019-2024 | Na, Va-Lcp |
| Maxx Orthopedics, INC. | $314.65 | 2019 | |
| Ferring Pharmaceuticals INC. | $190.70 | 2024-2025 | Euflexxa |
| Tactile Systems Technology INC | $173.53 | 2021-2022 | |
| Medtronic, INC. | $170.74 | 2022 | |
| Corin USA | $151.92 | 2019 | |
| Sanara Medtech INC. | $116.84 | 2022 | |
| Organogenesis INC. | $90.74 | 2021 | |
| Next Science LLC | $82.50 | 2022 | |
| Heron Therapeutics, INC. | $77.30 | 2025 | Zynrelef |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $41.83 | 2023 | |
| Abbott Laboratories | $17.90 | 2023 | Axium |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mccrosson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.